Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity - Wilhelm, S M; Dumas, J; Adnane, L (Int J Cancer, 2011)
, et al.